Billion-dollar bio-based chemicals IPO window is open, as Solazyme IPOs and Myriant files

June 02, 2011 | Analyst Insight

Solazyme's much-anticipated initial public offering (IPO) finally happened last Friday, selling about 11 million shares at $18 – raising $198 million in total, twice what it expected when it filed (see...